Tau and DNA Damage in Neurodegeneration
- PMID: 33297375
- PMCID: PMC7762255
- DOI: 10.3390/brainsci10120946
Tau and DNA Damage in Neurodegeneration
Abstract
Neurodegenerative disorders are a family of incurable conditions. Among them, Alzheimer's disease and tauopathies are the most common. Pathological features of these two disorders are synaptic loss, neuronal cell death and increased DNA damage. A key pathological protein for the onset and progression of the conditions is the protein tau, a microtubule-binding protein highly expressed in neurons and encoded by the MAPT (microtubule-associated protein tau) gene. Tau is predominantly a cytosolic protein that interacts with numerous other proteins and molecules. Recent findings, however, have highlighted new and unexpected roles for tau in the nucleus of neuronal cells. This review summarizes the functions of tau in the metabolism of DNA, describing them in the context of the disorders.
Keywords: Alzheimer’s disease; DNA damage; tau.
Conflict of interest statement
The authors declare no conflict of interests.
Figures


Similar articles
-
Genetic forms of tauopathies: inherited causes and implications of Alzheimer's disease-like TAU pathology in primary and secondary tauopathies.J Neurol. 2024 Jun;271(6):2992-3018. doi: 10.1007/s00415-024-12314-3. Epub 2024 Mar 30. J Neurol. 2024. PMID: 38554150 Free PMC article. Review.
-
Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.Adv Exp Med Biol. 2019;1184:145-166. doi: 10.1007/978-981-32-9358-8_13. Adv Exp Med Biol. 2019. PMID: 32096036 Review.
-
Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?Oxid Med Cell Longev. 2015;2015:151979. doi: 10.1155/2015/151979. Epub 2015 Oct 20. Oxid Med Cell Longev. 2015. PMID: 26576216 Free PMC article. Review.
-
Tau and MAPT genetics in tauopathies and synucleinopathies.Parkinsonism Relat Disord. 2021 Sep;90:142-154. doi: 10.1016/j.parkreldis.2021.09.008. Epub 2021 Sep 14. Parkinsonism Relat Disord. 2021. PMID: 34593302 Free PMC article. Review.
-
Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.J Neurochem. 2016 Apr;137(1):12-25. doi: 10.1111/jnc.13532. Epub 2016 Feb 11. J Neurochem. 2016. PMID: 26756400 Review.
Cited by
-
Sting and p53 DNA repair pathways are compromised in Alzheimer's disease.Sci Rep. 2023 May 23;13(1):8304. doi: 10.1038/s41598-023-35533-6. Sci Rep. 2023. PMID: 37221295 Free PMC article.
-
Insights into the Pathogenesis of Neurodegenerative Diseases: Focus on Mitochondrial Dysfunction and Oxidative Stress.Int J Mol Sci. 2021 Oct 31;22(21):11847. doi: 10.3390/ijms222111847. Int J Mol Sci. 2021. PMID: 34769277 Free PMC article. Review.
-
Tau mediates the reshaping of the transcriptional landscape toward intermediate Alzheimer's disease stages.Front Cell Dev Biol. 2025 Jan 3;12:1459573. doi: 10.3389/fcell.2024.1459573. eCollection 2024. Front Cell Dev Biol. 2025. PMID: 39830212 Free PMC article.
-
Glaucoma as a Tauopathy-Is It the Missing Piece in the Glaucoma Puzzle?J Clin Med. 2023 Nov 2;12(21):6900. doi: 10.3390/jcm12216900. J Clin Med. 2023. PMID: 37959365 Free PMC article. Review.
-
Failure of DNA double-strand break repair by tau mediates Alzheimer's disease pathology in vitro.Commun Biol. 2022 Apr 13;5(1):358. doi: 10.1038/s42003-022-03312-0. Commun Biol. 2022. PMID: 35418705 Free PMC article.
References
-
- Goedert M., Spillantini M.G. Ordered Assembly of Tau Protein and Neurodegeneration. In: Takashima A., Wolozin B., Buee L., editors. Tau Biology. Springer; Singapore: 2019. pp. 3–21. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources